Catalysts for $BNTX
3 tracked
Nov 3, 2026
earnings
BioNTech SE earnings
BioNTech SE
→
May 5, 2026
earnings
BioNTech SE earnings
BioNTech SE
→
RECRUITING
phase readout
NCT06827236: A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
BioNTech SE
→